Cushing’s syndrome screening with the 1-mg dexamethasone suppression test in metabolically healthy and unhealthy obesity phenotypes
While the 1 mg DST is a practical screening test for CS with high specificity in obesity, the number of CS cases detected remains relatively low. Therefore, it may be more reasonable and applicable to screen patients with MUO phenotype rather than all individuals with obesity.
Authors
- Sema Hepşen (ORCID: https://orcid.org/0000-0002-8375-7409)
- Pınar Akhanlı (ORCID: https://orcid.org/0000-0002-1662-3363)
- Muhammed Kızılgül (ORCID: https://orcid.org/0000-0002-8468-9196)
- Hayri Bostan (ORCID: https://orcid.org/0000-0002-4957-9856)
- İlknur Öztürk Ünsal (ORCID: https://orcid.org/0000-0003-3999-6426)
- Umran Gul
- Muhammed Erkam Sencar (ORCID: https://orcid.org/0000-0001-5581-4886)
- Erman Cakal
Institutions
- Canakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi (TR)
- Memorial Ankara Hospital (TR)
- Erzurum Regional Training and Research Hospital (TR)
Publication Details
- Journal
- International Journal of Obesity
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1038/s41366-024-01598-0
- Citations
- 1
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.36